Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |